isotretinoin 40 mg
1 INDICATIONS AND USAGE Isotretinoin capsules are indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, isotretinoin capsules are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. Isotretinoin capsules are retinoids indicated for the treatment of severe recalcitrant nodular acne in non-pregnant patients 12 years of age and older with multiple inflammatory nodules with a diameter of 5 mm or greater. Because of significant adverse reactions associated with its use, isotretinoin capsules are reserved for patients with severe nodular acne who are unresponsive to conventional therapy, including systemic antibiotics. ( 1 ) Limitations of Use : If a second course of isotretinoin therapy is needed, it is not recommended before a two-month waiting period because the patient's acne may continue to improve following a 15 to 20-week course of therapy. ( 1 ) Limitations of Use : If a second course of isotretinoin therapy is needed, it is not recommended before a two-month waiting period because the patient's acne may continue to improve following a 15 to 20-week course of therapy [see Dosage and Administration (2.2) ] .
upsher-smith laboratories, llc
OVAL BROWN 575
Related Pills
isotretinoin 30 mg
upsher-smith laboratories, llc
isotretinoin 20 mg
upsher-smith laboratories, llc
isotretinoin 10 mg
upsher-smith laboratories, llc
Metformin hydrochloride 500 MG sitagliptin 50 MG Oral Tablet Janumet
Merck Sharp & Dohme Corp.
ropinirole 3 MG Oral Tablet
West-Ward Pharmaceuticals Corp.
ibandronate sodium tablet
dr. reddy's laboratories limited
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING 10 mg: yellow, oblong, opaque, soft gelatin capsule, containing a yellow/orange viscous liquid, imprinted "570" in black ink. Box of 30 capsules (3 × 10 Prescription Packs): NDC 0245-0570-01 20 mg: pink, oblong, opaque, soft gelatin capsule, containing a yellow/orange viscous liquid, imprinted "571" in black ink. Box of 30 capsules (3 × 10 Prescription Packs): NDC 0245-0571-01 30 mg: brown, oblong, opaque, soft gelatin capsule, containing a yellow/orange viscous liquid, imprinted "573" in black ink. Box of 30 capsules (3 × 10 Prescription Packs): NDC 0245-0573-01 Storage and Handling Store at 20° to 25°C (68° to 77°F); excursion permitted between 15° to 30°C (59° to 86°F) [See USP Controlled Room Temperature]. Protect from light.
More pills like OVAL 575